Cargando…

Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion

Sialic acid immunoglobulin-like lectin (Siglec)-6 is a transmembrane receptor that binds leptin. Leptin is an obesity-associated peptide hormone overexpressed in gestational trophoblastic disease (GTD). GTD encompasses several placental abnormalities that range from benign to malignant. Among GTD, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rumer, Kristen K, Post, Miriam D, Larivee, Rhea S, Zink, Martina, Uyenishi, Jill, Kramer, Anita, Teoh, Deanna, Bogart, Kevin, Winn, Virginia D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Endocrinology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500471/
https://www.ncbi.nlm.nih.gov/pubmed/23089140
http://dx.doi.org/10.1530/ERC-11-0379
_version_ 1782250114397503488
author Rumer, Kristen K
Post, Miriam D
Larivee, Rhea S
Zink, Martina
Uyenishi, Jill
Kramer, Anita
Teoh, Deanna
Bogart, Kevin
Winn, Virginia D
author_facet Rumer, Kristen K
Post, Miriam D
Larivee, Rhea S
Zink, Martina
Uyenishi, Jill
Kramer, Anita
Teoh, Deanna
Bogart, Kevin
Winn, Virginia D
author_sort Rumer, Kristen K
collection PubMed
description Sialic acid immunoglobulin-like lectin (Siglec)-6 is a transmembrane receptor that binds leptin. Leptin is an obesity-associated peptide hormone overexpressed in gestational trophoblastic disease (GTD). GTD encompasses several placental abnormalities that range from benign to malignant. Among GTD, molar placentas are characterized by excess proliferation, whereas gestational trophoblastic neoplasias (GTN) have characteristically aggressive invasion. We hypothesized that in GTD, Siglec-6 expression would increase with disease severity and that Siglec-6 and leptin would promote proliferation, inhibit apoptosis and/or promote invasion. Siglec-6 expression patterns were evaluated with particular attention to the diagnostic utility of Siglec-6 in GTD (controls: normal placentas (n=32), hydropic abortus placentas (n=7), non-GTD reproductive tract cancers (n=2); GTD: partial moles (PM; n=11), complete moles (n=24), GTN (n=6)). In normal placentas, Siglec-6 expression dramatically decreased after 8 weeks gestation. Complete molar placentas had significantly higher Siglec-6 expression than controls, but expression was not significantly different from PM. In GTN, Siglec-6 expression was low. These data suggest that Siglec-6 may have diagnostic utility for distinguishing complete moles from normal and hydropic abortus placentas. Functional studies in choriocarcinoma-derived BeWO cells demonstrated a complex interplay between Siglec-6 expression and leptin exposure. In cells lacking Siglec-6, leptin treatment promoted invasion, likely through interaction with LepR leptin receptor, without affecting proliferation or apoptosis. Siglec-6 expression promoted proliferation in a leptin-dependent manner, but protected cells from apoptosis and promoted invasion in a leptin-independent manner. We propose that Siglec-6 and leptin play a role in the aberrant properties characteristic of GTD, namely excess proliferation and invasion.
format Online
Article
Text
id pubmed-3500471
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Society for Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-35004712012-12-01 Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion Rumer, Kristen K Post, Miriam D Larivee, Rhea S Zink, Martina Uyenishi, Jill Kramer, Anita Teoh, Deanna Bogart, Kevin Winn, Virginia D Endocr Relat Cancer Regular Papers Sialic acid immunoglobulin-like lectin (Siglec)-6 is a transmembrane receptor that binds leptin. Leptin is an obesity-associated peptide hormone overexpressed in gestational trophoblastic disease (GTD). GTD encompasses several placental abnormalities that range from benign to malignant. Among GTD, molar placentas are characterized by excess proliferation, whereas gestational trophoblastic neoplasias (GTN) have characteristically aggressive invasion. We hypothesized that in GTD, Siglec-6 expression would increase with disease severity and that Siglec-6 and leptin would promote proliferation, inhibit apoptosis and/or promote invasion. Siglec-6 expression patterns were evaluated with particular attention to the diagnostic utility of Siglec-6 in GTD (controls: normal placentas (n=32), hydropic abortus placentas (n=7), non-GTD reproductive tract cancers (n=2); GTD: partial moles (PM; n=11), complete moles (n=24), GTN (n=6)). In normal placentas, Siglec-6 expression dramatically decreased after 8 weeks gestation. Complete molar placentas had significantly higher Siglec-6 expression than controls, but expression was not significantly different from PM. In GTN, Siglec-6 expression was low. These data suggest that Siglec-6 may have diagnostic utility for distinguishing complete moles from normal and hydropic abortus placentas. Functional studies in choriocarcinoma-derived BeWO cells demonstrated a complex interplay between Siglec-6 expression and leptin exposure. In cells lacking Siglec-6, leptin treatment promoted invasion, likely through interaction with LepR leptin receptor, without affecting proliferation or apoptosis. Siglec-6 expression promoted proliferation in a leptin-dependent manner, but protected cells from apoptosis and promoted invasion in a leptin-independent manner. We propose that Siglec-6 and leptin play a role in the aberrant properties characteristic of GTD, namely excess proliferation and invasion. Society for Endocrinology 2012-12 /pmc/articles/PMC3500471/ /pubmed/23089140 http://dx.doi.org/10.1530/ERC-11-0379 Text en © 2012 Society for Endocrinology http://www.endocrinology.org/journals/reuselicence/ This is an Open Access article distributed under the terms of the Society for Endocrinology's Re-use Licence (http://www.endocrinology.org/journals/reuselicence/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Papers
Rumer, Kristen K
Post, Miriam D
Larivee, Rhea S
Zink, Martina
Uyenishi, Jill
Kramer, Anita
Teoh, Deanna
Bogart, Kevin
Winn, Virginia D
Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title_full Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title_fullStr Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title_full_unstemmed Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title_short Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
title_sort siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
topic Regular Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500471/
https://www.ncbi.nlm.nih.gov/pubmed/23089140
http://dx.doi.org/10.1530/ERC-11-0379
work_keys_str_mv AT rumerkristenk siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT postmiriamd siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT lariveerheas siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT zinkmartina siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT uyenishijill siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT krameranita siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT teohdeanna siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT bogartkevin siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion
AT winnvirginiad siglec6isexpressedingestationaltrophoblasticdiseaseandaffectsproliferationapoptosisandinvasion